Groesbeck Investment Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-62
Closed -$6K 101
2026
Q1
$6K Hold
62
0.01% 89
2025
Q4
$5K Buy
+62
New +$5.19K 0.01% 90

Other funds holding ACLS

Groesbeck Investment Management's ACLS Position: Q2 2026 in Review

Groesbeck Investment Management sold out of Axcelis (ACLS) in Q2 2026, closing a stake of 62 shares — an estimated $6K sold.

Groesbeck Investment Management first reported a position in ACLS in Q4 2025 and held it in 2 quarters. The position peaked at $6K in Q1 2026. 56 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Groesbeck Investment Management reported no remaining Axcelis position as of Q2 2026 after selling out during the quarter.
  • Groesbeck Investment Management sold 62 Axcelis shares in Q2 2026, an estimated $6K.
  • Groesbeck Investment Management first reported a position in Axcelis in Q4 2025 and held it in 2 quarters.
  • Groesbeck Investment Management's Axcelis position peaked at $6K in Q1 2026.
  • 56 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Groesbeck Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.